{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T13:03:51Z","timestamp":1780319031747,"version":"3.54.1"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:p>Atopic dermatitis, the most common inflammatory skin disease of childhood, affects up to 20% of US children and frequently prompts emergency department (ED) visits. Clinicians must distinguish uncomplicated flares from secondary infections or treatment complications and initiate appropriate acute interventions. Evidence supports the judicious use of topical corticosteroids, with systemic therapy reserved for severe or refractory cases. The therapeutic landscape has expanded to include biological and targeted agents, which, while generally initiated in specialty settings, influence long-term care and require awareness in the ED. Families benefit from structured, actionable discharge planning, including provision of an \u201cEczema Action Plan,\u201d clear instructions on topical regimens, moisturizer use, and guidance on follow-up with primary care and dermatology. Emphasis on communication and education helps prevent recurrence, reduces unscheduled visits, and fosters adherence to outpatient management.<\/jats:p>","DOI":"10.1097\/pec.0000000000003557","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T12:01:42Z","timestamp":1780315302000},"page":"483-490","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Update on the Clinical Management of Atopic Dermatitis in the Pediatric Emergency Department"],"prefix":"10.1097","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0802-0279","authenticated-orcid":false,"given":"Peter Y.","family":"Ch\u2019en","sequence":"first","affiliation":[{"name":"Resident, Department of Dermatology, University of Washington, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisa","family":"McQueen","sequence":"additional","affiliation":[{"name":"Associate Professor of Emergency Medicine, Rush Medical College"},{"name":"Attending Physician, Pediatric Emergency Medicine John H. Stroger, Jr. Hospital of Cook County, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7600-0152","authenticated-orcid":false,"given":"Peter A.","family":"Lio","sequence":"additional","affiliation":[{"name":"Clinical Professor of Dermatology and Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"key":"R1-20260601","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/pde.14476","article-title":"Evaluation of emergency department utilization for dermatologic conditions in the pediatric population within the United States from 2009-2015","volume":"38","author":"Collier","year":"2021","journal-title":"Pediatr Dermatol"},{"key":"R2-20260601","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1111\/j.1468-3083.2010.03672.x","article-title":"High frequency, diversity and severity of skin diseases in a paediatric emergency department","volume":"24","author":"Kramkimel","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R3-20260601","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.jaad.2016.01.021","article-title":"Emergency department utilization of pediatric dermatology (PD) consultations","volume":"74","author":"Moon","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"R4-20260601","article-title":"Dermatology so. Atopic dermatitis: update on skin-directed management: clinical report","volume":"155:e2025071812","author":"Schoch","year":"2025","journal-title":"Pediatrics"},{"key":"R5-20260601","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jaad.2018.05.025","article-title":"Financial burden of emergency department visits for atopic dermatitis in the United States","volume":"79","author":"Kwa","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"R6-20260601","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMra2023911","article-title":"Atopic dermatitis","volume":"384","author":"St\u00e4nder","year":"2021","journal-title":"N Engl J Med"},{"key":"R7-20260601","doi-asserted-by":"crossref","first-page":"e70130","DOI":"10.1111\/pai.70130","article-title":"Environmental factors shaping atopic dermatitis: lessons from longitudinal cohort studies","volume":"36","author":"Lee","year":"2025","journal-title":"Pediatr Allergy Immunol"},{"key":"R8-20260601","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.jid.2024.01.011","article-title":"Adding fuel to the fire? The skin microbiome in atopic dermatitis","volume":"144","author":"Saheb Kashaf","year":"2024","journal-title":"J Invest Dermatol"},{"key":"R9-20260601","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.jid.2024.01.001","article-title":"Staphylococcus aureus: the bug behind the itch in atopic dermatitis","volume":"144","author":"Gallo","year":"2024","journal-title":"J Invest Dermatol"},{"key":"R10-20260601","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/jdv.18225","article-title":"Atopic dermatitis: pathomechanisms and lessons learned from novel systemic therapeutic options","volume":"36","author":"Bieber","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R12-20260601","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jaad.2005.12.028","article-title":"Corticosteroid classes: a quick reference guide including patch test substances and cross-reactivity","volume":"54","author":"Jacob","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"R13-20260601","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jaad.2023.08.103","article-title":"Executive summary: guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies","volume":"90","author":"Davis","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"R14-20260601","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jaad.2022.12.029","article-title":"Guidelines of care for the management of atopic dermatitis in adults with topical therapies","volume":"89","author":"Sidbury","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"R15-20260601","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jaad.2014.03.030","article-title":"Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents","volume":"71","author":"Sidbury","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"R16-20260601","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1365-2133.2009.09561.x","article-title":"Prednisolone vs. ciclosporin for severe adult eczema. An investigator-initiated double-blind placebo-controlled multicentre trial","volume":"162","author":"Schmitt","year":"2010","journal-title":"Br J Dermatol"},{"key":"R17-20260601","doi-asserted-by":"crossref","first-page":"e2423563","DOI":"10.1001\/jamanetworkopen.2024.23563","article-title":"Long-term use of oral corticosteroids and safety outcomes for patients with atopic dermatitis","volume":"7","author":"Jang","year":"2024","journal-title":"JAMA Network Open"},{"key":"R18-20260601","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1056\/NEJMoa1314768","article-title":"Dupilumab treatment in adults with moderate-to-severe atopic dermatitis","volume":"371","author":"Beck","year":"2014","journal-title":"N Engl J Med"},{"key":"R19-20260601","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1001\/jamadermatol.2021.3023","article-title":"Efficacy and safety of upadacitinib vs dupilumab in adults with moderate-to-severe atopic dermatitis: a randomized clinical trial","volume":"157","author":"Blauvelt","year":"2021","journal-title":"JAMA Dermatology"},{"key":"R20-20260601","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1001\/archderm.141.12.1556","article-title":"Soak and smear: a standard technique revisited","volume":"141","author":"Gutman","year":"2005","journal-title":"Arch Dermatol"},{"key":"R21-20260601","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/bjd.15165","article-title":"Efficacy and safety of wet wrap therapy for patients with atopic dermatitis: a systematic review and meta-analysis","volume":"177","author":"Gonz\u00e1lez-L\u00f3pez","year":"2017","journal-title":"Br J Dermatol"}],"container-title":["Pediatric Emergency Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PEC.0000000000003557","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T12:01:45Z","timestamp":1780315305000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PEC.0000000000003557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/pec.0000000000003557","relation":{},"ISSN":["0749-5161","1535-1815"],"issn-type":[{"value":"0749-5161","type":"print"},{"value":"1535-1815","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"2025-10-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}